Systemic lupus erythematosus--survival patterns. Experience with 609 patients

Area of Science:

• Rheumatology
• Internal Medicine
• Nephrology

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with variable prognosis.
• Understanding long-term survival and prognostic factors in SLE is crucial for patient management.
• Prior studies highlight nephritis as a significant predictor of mortality in SLE.

Purpose of the Study:

• To evaluate the ten-year survival rates of private SLE patients.
• To identify prognostic factors influencing survival in SLE.
• To assess the impact of nephritis and its characteristics on SLE patient outcomes.

Main Methods:

• Longitudinal follow-up of 609 private patients with SLE for a mean of ten years.
• Data collection on demographics, diagnosis timing, nephritis presence, and clinical characteristics.
• Survival analysis comparing outcomes based on nephritis status, age, sex, and race.

Main Results:

• Overall ten-year survival was 79% (87% without nephritis, 65% with nephritis).
• Male SLE patients had poorer survival than females; no significant white vs. nonwhite difference.
• Nephrotic syndrome at nephritis onset was a poor prognostic sign; renal disease and sepsis were leading causes of death.

Conclusions:

• Nephritis is a major determinant of poor prognosis in SLE patients.
• Early detection and management of nephritis, particularly with nephrotic syndrome, are critical.
• Improved survival may be linked to enhanced follow-up, nutrition, and early intervention strategies.